Reports
Sale
Global Cancer Registry Software Market Size, Share, Report: By Software Type: Standalone, Integrated; By Database; Public Data, Commercial Data; Deployment Type: Cloud-based, On-Premises; By Functionality: Cancer Reporting, Patient Care, Medical Research; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Cancer Registry Software Market Outlook
The global cancer registry software market size was valued at USD 72.3 million in 2023, driven by the rising incidence of cancer and the prevalence of EHR (electronic health record). across the globe. The market is expected to grow at a CAGR of 10.4% during the forecast period of 2024-2032, with the values likely to rise from USD 79.8 million in 2024 to USD 175.8 million by 2032.
Cancer Registry Software: Introduction
A cancer registry is an information system crafted to streamline the collection, processing, and management process of cancer-related data in patients. It plays a vital role in data surveillance as it helps identify the key areas for intervention to prevent the increasing incidence of cancer.
Cancer registry software can help in treatment development for cancer. It can be a pivotal tool to identify potential risk factors of cancer like excessive sun or chemical exposure. The collected data can be further used for identifying locations where proper care and awareness are needed.
Global Cancer Registry Software Market Analysis
With the incidence of cancer cases and digitization trends, medical practitioners have started inclining towards software and digital platforms to streamline and organize vast amounts of data efficiently, contributing to improved patient outcomes Hence, the cancer registry software market demand has increased in the historic period.
Registry Plus, developed by the Centers and Disease Control and Prevention, is an array of publicly available free software programs compliant with national standards. These programs implement the National Program of Cancer Registries (NPCR), established by Public Law 102-515. It has become a common platform among several cancer registries.
The cancer registry software market value is also expected to grow with the onset of software enabled with improved security features. For example, the latest iteration of Abstract Plus (version 6.0) includes security features like user roles, challenge questions and passwords. Additionally, all records are securely stored in Microsoft® Access, with an extra layer of protection through password encryption on all tables.
As this software offers a high degree of flexibility, it can also be customized by hospitals, clinics, laboratories, and other cancer data sources. This adaptability indicates a promising trajectory for the global market of cancer registry software in the forecast period.
Global Cancer Registry Software Market Segmentation
Market Breakup by Software Type
- Standalone
- Integrated
Market Breakup by Database
- Public Data
- Commercial Data
Market Breakup by Deployment Type
- Cloud-Based
- On-Premise
Market Breakup by Functionality
- Cancer Reporting
- Patient Care
- Medical Research
Market Breakup by End User
- Government Organization
- Hospital and Medical Practices
- Research Centres and Private Payers
- Pharmaceutical, Biotechnology and Medical Device Companie
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Cancer Registry Software Market Overview
As per the American Cancer Society Journal, in 2023 around 1,958,310 new cancer cases and 609,820 cancer deaths are estimated to occur in the United States only. Consequently, the United States is expected to dominate the cancer registry software market share. With the authorities getting more alert and proficient in spreading relevant information through awareness campaigns, the market size is anticipated to increase. In addition, the presence of a digital equipped infrastructure is also attributed to driving the market.
The Asia Pacific is expected to lead the market, as the governments are getting informed and committed to constructing infrastructures aligned with technological advancements. The ongoing digitalization efforts across countries and a rising prevalence of telemedicine contribute to a significant surge in digital platforms and services. For instance, in India, the National Cancer Grid has installed the Koita Centre for Digital Oncology (KCDO). This centre promotes the application of digital technologies and tools to improve cancer care across the country. Such initiatives indicate that the cancer registry software market growth is certain in the future.
Global Cancer Registry Software Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Centers for Disease Control and Prevention
- IBM Corporation
- Onco, Inc
- Elekta AB (pub)
- C/NET Solution
- Ordinal Data, Inc
- Conduent, Inc
- himagine solutions
- McKesson Corporation
- IACR Official Website
- F. Hoffmann-La Roche Ltd
- NeuralFrame, Inc
- IARC
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Software Type |
|
| Breakup by Database |
|
| Breakup by Deployment Type |
|
| Breakup by Functionality |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cancer Registry Software Market Overview
3.1 Global Cancer Registry Software Market Historical Value (2017-2023)
3.2 Global Cancer Registry Software Market Forecast Value (2024-2032)
4 Global Cancer Registry Software Market Landscape
4.1 Global Cancer Registry Software Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cancer Registry Software Product Landscape
4.2.1 Analysis by Software Type
4.2.2 Analysis by Database
4.2.3 Analysis by Deployment Type
4.2.4 Analysis by Functionality
5 Global Cancer Registry Software Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cancer Registry Software Market Segmentation
6.1 Global Cancer Registry Software Market by Software Type
6.1.1 Market Overview
6.1.2 Standalone
6.1.3 Integrated
6.2 Global Cancer Registry Software Market by Database
6.2.1 Market Overview
6.2.2 Public Data
6.2.3 Commercial Data
6.3 Global Cancer Registry Software Market by Deployment Type
6.3.1 Market Overview
6.3.2 Cloud-based
6.3.3 On-Premises
6.4 Global Cancer Registry Software Market by Functionality
6.4.1 Market Overview
6.4.2 Cancer Reporting
6.4.3 Patient Care
6.4.4 Medical Research
6.5 Global Cancer Registry Software Market by End User
6.5.1 Market Overview
6.5.2 Government Organization
6.5.3 Hospital and Medical Practices
6.5.4 Research Centres and Private Payers
6.5.5 Pharmaceutical, Biotechnology and Medical Device Companies
6.5.6 Others
6.6 Global Cancer Registry Software Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Cancer Registry Software Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cancer Registry Software Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cancer Registry Software Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cancer Registry Software Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cancer Registry Software Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding & Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Centers for Disease Control and Prevention
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 IBM Corporation
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Onco, Inc
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Elekta AB (pub)
16.4.1 Financial Analysis
16.4.2 Financial Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 C/NET Solution
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Ordinal Data, Inc
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Conduent, Inc
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 himagine solutions
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 McKesson Corporation
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 IACR Official Website
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 F. Hoffmann-La Roche Ltd
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
16.12 NeuralFrame, Inc
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisitions
16.12.5 Certifications
16.13 IARC
16.13.1 Financial Analysis
16.13.2 Product Portfolio
16.13.3 Demographic Reach and Achievements
16.13.4 Mergers and Acquisitions
16.13.5 Certifications
17 Global Cancer Registry Software Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 72.3 billion in 2023, driven by the prevalence of cancer cases across the globe.
The market is anticipated to grow at a CAGR of 10.4% during the forecast period of 2024-2032, likely to reach a market value of USD 175.8 billion by 2032.
Market demand has increased with the arrival of digital platforms and software to streamline patient data and develop customised treatment alternatives for them.
The current market trend involves the increasing prevalence of telemedicine, contributing to a significant surge in digital platforms and services. For example, in India, the National Cancer Grid has launched the Koita Centre for Digital Oncology (KCDO) to promote digital technologies and tools application for cancer treatment.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Software types include standalone and integrated.
Cancer reporting, patient care, and medical research are the major functionality areas.
It includes cloud-based and on-premises deployment types.
Database is divided into public and commercial data.
Major end users include government organizations, hospital and medical practices, research centres and private payers, pharmaceutical, biotechnology, and medical device companies, among others.
Key players involved in the market are Centers for Disease Control and Prevention, IBM Corporation, Onco, Inc., Elekta AB (pub), C/NET Solution, Ordinal Data, Inc., Conduent, Inc., himagine solutions, McKesson Corporation, IACR Official Website, F. Hoffmann-La Roche Ltd, NeuralFrame, Inc and IARC.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER